Kevin W. Ward

1.1k total citations
26 papers, 885 citations indexed

About

Kevin W. Ward is a scholar working on Infectious Diseases, Molecular Medicine and Endocrinology. According to data from OpenAlex, Kevin W. Ward has authored 26 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Molecular Medicine and 11 papers in Endocrinology. Recurrent topics in Kevin W. Ward's work include Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Kevin W. Ward is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Bacterial Identification and Susceptibility Testing (9 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Kevin W. Ward collaborates with scholars based in United States, Australia and United Kingdom. Kevin W. Ward's co-authors include David A. Bruckner, Janet Hindler, Guiqing Wang, Romney M. Humphries, Janet A. Hindler, Shangxin Yang, Peera Hemarajata, Aric L. Gregson, Shelley A. Miller and Michael A. Lewinski and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Kevin W. Ward

25 papers receiving 853 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin W. Ward United States 13 424 380 315 258 195 26 885
Maria M. Traczewski United States 18 312 0.7× 487 1.3× 293 0.9× 232 0.9× 253 1.3× 42 924
Matthew G. Stilwell United States 15 457 1.1× 401 1.1× 327 1.0× 334 1.3× 270 1.4× 20 1.0k
Steve H. Marshall United States 13 373 0.9× 579 1.5× 242 0.8× 209 0.8× 210 1.1× 18 930
Jui‐Fen Lai Taiwan 19 310 0.7× 406 1.1× 189 0.6× 135 0.5× 277 1.4× 28 920
Marta Tato Spain 17 365 0.9× 573 1.5× 193 0.6× 240 0.9× 281 1.4× 33 1.0k
Michael Malczynski United States 14 209 0.5× 410 1.1× 201 0.6× 170 0.7× 208 1.1× 40 905
Gabriella Parisi Italy 10 212 0.5× 321 0.8× 215 0.7× 132 0.5× 245 1.3× 22 655
Anna Both Germany 16 284 0.7× 243 0.6× 242 0.8× 128 0.5× 155 0.8× 43 813
Suzane Silbert United States 17 281 0.7× 592 1.6× 241 0.8× 139 0.5× 240 1.2× 51 1.0k
María Ángeles Orellana Spain 20 336 0.8× 428 1.1× 171 0.5× 109 0.4× 370 1.9× 60 1.0k

Countries citing papers authored by Kevin W. Ward

Since Specialization
Citations

This map shows the geographic impact of Kevin W. Ward's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin W. Ward with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin W. Ward more than expected).

Fields of papers citing papers by Kevin W. Ward

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin W. Ward. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin W. Ward. The network helps show where Kevin W. Ward may publish in the future.

Co-authorship network of co-authors of Kevin W. Ward

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin W. Ward. A scholar is included among the top collaborators of Kevin W. Ward based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin W. Ward. Kevin W. Ward is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhuo, Ran, et al.. (2024). Carbapenem resistant Campylobacter jejuni bacteremia in a Bruton’s X-linked agammaglobulinemia patient. European Journal of Clinical Microbiology & Infectious Diseases. 43(12). 2459–2463. 1 indexed citations
2.
Realegeno, Susan, Kevin W. Ward, Omai B. Garner, & Shangxin Yang. (2021). Deceiving Phenotypic Susceptibility Results on a Klebsiella pneumoniae Blood Isolate Carrying Plasmid-Mediated AmpC Gene blaDHA-1. Frontiers in Cellular and Infection Microbiology. 11. 561880–561880. 8 indexed citations
3.
Price, Travis K., Kevin W. Ward, Evann E. Hilt, et al.. (2021). Genomic Characterizations of Clade III Lineage of Candida auris, California, USA. Emerging infectious diseases. 27(4). 1223–1227. 16 indexed citations
4.
Price, Travis K., Kusha Davar, Deisy Contreras, et al.. (2021). Case Report and Genomic Analysis of Cefiderocol-Resistant Escherichia coli Clinical Isolates. American Journal of Clinical Pathology. 157(2). 257–265. 11 indexed citations
5.
Kamau, Edwin, et al.. (2021). Endogenous Endophthalmitis Caused by ST66-K2 Hypervirulent Klebsiella pneumoniae, United States. Emerging infectious diseases. 27(8). 2215–2218. 9 indexed citations
6.
7.
Hilt, Evann E., Sean Fitzwater, Kevin W. Ward, et al.. (2020). Carbapenem Resistant Aeromonas hydrophila Carrying blacphA7 Isolated From Two Solid Organ Transplant Patients. Frontiers in Cellular and Infection Microbiology. 10. 563482–563482. 14 indexed citations
8.
Yang, Shangxin, Peera Hemarajata, Janet A. Hindler, et al.. (2015). Investigation of a suspected nosocomial transmission of blaKPC3-mediated carbapenem-resistant Klebsiella pneumoniae by whole genome sequencing. Diagnostic Microbiology and Infectious Disease. 84(4). 337–342. 12 indexed citations
9.
Yang, Shangxin, Peera Hemarajata, Janet Hindler, et al.. (2015). Identification of Klebsiella pneumoniae Producing OXA-232 and CTX-M-15 by Whole-Genome Sequencing Analysis. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations
10.
Najarian, Kayvan, et al.. (2012). Automated computer-aided decision support for traumatic pelvic and abdominal injuries. SPIE Newsroom. 1 indexed citations
11.
Mochon, A. Brian, Omai B. Garner, Janet A. Hindler, et al.. (2011). New Delhi Metallo-β-Lactamase (NDM-1)-Producing Klebsiella pneumoniae: Case Report and Laboratory Detection Strategies. Journal of Clinical Microbiology. 49(6). 2386–2386. 3 indexed citations
12.
Kelesidis, Theodoros, Romney M. Humphries, Kevin W. Ward, Michael A. Lewinski, & Otto O. Yang. (2011). Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagnostic Microbiology and Infectious Disease. 71(3). 286–290. 40 indexed citations
13.
Kelesidis, Theodoros, Jennifer Dien Bard, Romney M. Humphries, et al.. (2010). First Report of Treatment of Anaerobiospirillum s ucciniciproducens Bloodstream Infection with Levofloxacin. Journal of Clinical Microbiology. 48(5). 1970–1973. 13 indexed citations
14.
Humphries, Romney M., Theodoros Kelesidis, Jennifer Dien Bard, et al.. (2010). Successful treatment of pan-resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. Journal of Medical Microbiology. 59(11). 1383–1386. 52 indexed citations
15.
Wang, Guiqing, Janet Hindler, Kevin W. Ward, & David A. Bruckner. (2006). Increased Vancomycin MICs for Staphylococcus aureus Clinical Isolates from a University Hospital during a 5-Year Period. Journal of Clinical Microbiology. 44(11). 3883–3886. 299 indexed citations
16.
Rowlinson, Marie‐Claire, et al.. (2006). Isolation of a Strictly Anaerobic Strain of Staphylococcus epidermidis. Journal of Clinical Microbiology. 44(3). 857–860. 8 indexed citations
17.
Linscott, Andrea J., Melinda D. Poulter, Kevin W. Ward, & David A. Bruckner. (2004). Legionella pneumophila Serogroup 4 Isolated from Joint Tissue. Journal of Clinical Microbiology. 42(3). 1365–1366. 9 indexed citations
18.
Hageman, Jeffrey, David A. Pegues, Rebecca Bell, et al.. (2001). Vancomycin-Intermediate Staphylococcus aureus in a Home Health-Care Patient. Emerging infectious diseases. 7(6). 1023–1025. 43 indexed citations
19.
Reinhardt, John F., Lynn Johnston, Peter Ruane, et al.. (1986). A Randomized, Double-Blind Comparison of Sulbactam/Ampicillin and Clindamycin for the Treatment of Aerobic and Aerobic-Anaerobic Infections. Clinical Infectious Diseases. 8(Supplement_5). S569–S575. 25 indexed citations
20.
Ward, Kevin W., et al.. (1982). Cefotaxime clinical trial results in septicaemic patients in Ireland and the U.K.. PubMed. 75(1). 10–1. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria M. Traczewski Breakdown of academic impact, for papers by Matthew G. Stilwell Breakdown of academic impact, for papers by Steve H. Marshall Breakdown of academic impact, for papers by Jui‐Fen Lai Breakdown of academic impact, for papers by Marta Tato Breakdown of academic impact, for papers by Michael Malczynski Breakdown of academic impact, for papers by Gabriella Parisi Breakdown of academic impact, for papers by Anna Both Breakdown of academic impact, for papers by Suzane Silbert Breakdown of academic impact, for papers by María Ángeles Orellana
Rankless by CCL
2026